The ClinGen Evidence Repository is an FDA-recognized human genetic variant database containing expert-curated assertions regarding variants' pathogenicity and supporting evidence summaries. [Disclaimer]

  • No Criteria Specification was provided in the publication event for the variant classifaction.
  • The Criteria Specification shown below is a best-estimate based on the VCEP, gene, disease, and publication date.

Variant: NM_000277.3(PAH):c.563G>A (p.Gly188Asp)

CA229628

102738 (ClinVar)

Gene: PAH (HGNC:5053)
Condition: phenylketonuria (MONDO:0009861)
Inheritance Mode: Autosomal recessive inheritance
UUID: 1ebfcbe1-94c5-44ac-917b-3bb6d1edebc5
Approved on: 2019-11-18
Published on: 2021-04-09

HGVS expressions

NM_000277.3(PAH):c.563G>A (p.Gly188Asp)
NM_000277.3:c.563G>A
NC_000012.12:g.102855279C>T
CM000674.2:g.102855279C>T
NC_000012.11:g.103249057C>T
CM000674.1:g.103249057C>T
NC_000012.10:g.101773187C>T
NG_008690.1:g.67324G>A
NG_008690.2:g.108132G>A
ENST00000307000.7:c.548G>A
ENST00000553106.5:c.563G>A
NM_000277.1:c.563G>A
NM_000277.2:c.563G>A
NM_001354304.1:c.563G>A
NM_001354304.2:c.563G>A
More

Likely Pathogenic

Met criteria codes 4
PP4_Moderate PP3 PM2 PM3

Evidence Links 0

Expert Panel

Criteria Specification Information

Criteria Specifications for this VCEP
Evidence submitted by expert panel
Phenylketonuria VCEP
The c.563G>A (p.Gly188Asp) variant in PAH has been reported in 3 affected individuals (BH4 deficiency excluded). (PP4_Moderate; PMID: 23430918, 26503515, 22526846). This variant is absent in population databases (PM2). This variant was detected with pathogenic variants p.F55fs (parental analysis not reported, PMID: 22526846) and p.R243Q (in trans, PMID: 26322415; PM3). Computational evidence support a deleterious effect (PP3). In summary, this variant meets criteria to be classified as likely pathogenic for PAH. PAH-specific ACMG/AMP criteria applied: PP4_Moderate, PM2, PM3, PP3.
Met criteria codes
PP4_Moderate
Detected in a French patient with PKU (1383 pre-treatment); BH4 assessment not reported. PMID: 23430918. Detected in a Chinese patient with PKU; Dihydropteridine reductase activity, urinary biopterin and neopterin ratio, and tetrahydrobiopterin loading were assessed. PMID: 26503515. Detected in an Austrian patient with PKU PMID: 22526846
PP3
Deleterious effect predicted in SIFT, PolyPhen2, MutationTaster. REVEL=0.84.
PM2
Absent from controls in ExAC, gnomAD, 1000 Genomes, ESP
PM3
detected with p.F55fs (P by 4 submitters, LP by 1 submitter), parental analysis not reported, PMID: 22526846. Detected in trans with p.R243Q (P by 8 submitters) PMID: 26322415
Curation History
The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. If you have questions about the information contained on this website, please see a health care professional.
ClinGen Terms of Use.
¤ Powered by BCM's Genboree.